Corrigendum: "Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac".

[This corrects the article on p. 240 in vol. 5, PMID: 25628605.].

In Table 2, the section designated “Disabling of cell survival pathway gene expression,” line 5 incorrectly states “…pro-apoptotic miR-21”; the correct statement is “…pro-apoptotic miR-15A.” The issue is correctly discussed in the body of the published text, p. 2, right column, paragraph 4.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.